TXN
50
-3
IPG
39
-3
ORLY
57
-3
AA
41
-4
ED
53
4
MOS
19
-4
SIG
57
-3
MDT
53
-2
AVY
53
-9
BAC
41
-6
MU
34
3
DAL
62
-4
OMC
64
-2
COST
56
3
PYPL
43
-4
TSN
31
-4
SJM
38
-3
PCAR
50
-3
NRG
69
12
ISRG
68
-3
TXN
50
-3
IPG
39
-3
ORLY
57
-3
AA
41
-4
ED
53
4
MOS
19
-4
SIG
57
-3
MDT
53
-2
AVY
53
-9
BAC
41
-6
MU
34
3
DAL
62
-4
OMC
64
-2
COST
56
3
PYPL
43
-4
TSN
31
-4
SJM
38
-3
PCAR
50
-3
NRG
69
12
ISRG
68
-3
Financhill
Back

First Trust RBA Amer Indl RenaisTM ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
78

AIRR
First Trust RBA Amer Indl RenaisTM ETF

Last Price:
74.58
Seasonality Move:
5.68%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Buy
78
First Trust RBA Amer Indl RenaisTM ETF (AIRR) is a Buy

Is First Trust RBA Amer Indl RenaisTM ETF a Buy, Sell or Hold?

  • The current First Trust RBA Amer Indl RenaisTM ETF [AIRR] share price is $74.64. The Score for AIRR is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • AIRR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

AIRR Stock Price Chart

What is First Trust RBA Amer Indl RenaisTM ETF's stock price today?

  • The First Trust RBA Amer Indl RenaisTM ETF share price today is $74.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AIRR is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

AIRR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.82 Buy
Relative Strength Index (14 RSI): 64.66 Buy
Chaikin Money Flow: -65629 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (68.84 - 73.04) Buy
Bollinger Bands (100): (67.77 - 72.41) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

AIRR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72 Buy
20-day SMA: 71.03 Buy
50-day SMA: 70.94 Buy
200-day SMA: 65.12 Buy
8-day EMA: 72.55 Buy
20-day EMA: 71.28 Buy
50-day EMA: 70.55 Buy
200-day EMA: 65.4 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

First Trust RBA Amer Indl RenaisTM ETF Earnings Growth & AIRR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

First Trust RBA Amer Indl RenaisTM ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):